September 5, 2019 / 11:19 AM / 3 months ago

Cigna's new plan to cover multi-million dollar gene therapies

Sept 5 (Reuters) - Health insurer Cigna Corp on Thursday announced a new program that covers costs for expensive gene therapies that will cut out-of-pocket payments for customers.

Spark Therapeutics Inc and Novartis AG’s blindness therapy, Luxturna, and Novartis’ $2.1 million spinal muscular atrophy treatment, Zolgensma, will be the first two gene therapies included in the program, the company said. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D’Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below